Exon scanning by reverse transcriptase–polymerase chain reaction for detection of known and novel EML4–ALK fusion variants in non–small cell lung cancer
Authors:
- Heather R. SandersHSHeather R. Sanders
- Jean-Marie BrueyJBJean-Marie Bruey
- Maher AlbitarMAMaher Albitar
- 1 January 2011
- journal article
- research article
- Published by Elsevier in Cancer Genetics
- Vol. 204 (1) , 45-52
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- ALK Gene Rearrangements: A New Therapeutic Target in a Molecularly Defined Subset of Non-small Cell Lung CancerJournal of Thoracic Oncology, 2009
- Clinicopathologic Features of Non-Small-Cell Lung Cancer with EML4–ALK Fusion GeneAnnals of Surgical Oncology, 2009
- EML4-ALK: Honing In on a New Target in Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2009
- KIF5B-ALK, a Novel Fusion Oncokinase Identified by an Immunohistochemistry-based Diagnostic System for ALK-positive Lung CancerClinical Cancer Research, 2009
- The EML4‐ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild‐type EGFR and KRASCancer, 2009
- Multiplex Reverse Transcription-PCR Screening for EML4-ALK Fusion TranscriptsClinical Cancer Research, 2008
- EML4-ALKFusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung CancerClinical Cancer Research, 2008
- Identification of Novel Isoforms of theEML4-ALKTransforming Gene in Non–Small Cell Lung CancerCancer Research, 2008
- Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancerNature, 2007
- KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or ErlotinibPLOS Medicine, 2005